Abstract:Background Several observational studies have proposed a potential link between gut microbiota and the onset and progression of sepsis. Nevertheless, the causality of gut microbiota and sepsis remains debatable and warrants more comprehensive exploration. Methods We conducted a two-sample Mendelian randomization (MR) analysis to test the causality between gut microbiota and the onset and progression of sepsis. The genome-wide association study (GWAS) summary statistics for 196 bacterial traits were extracted from the MiBioGen consortium, whereas the GWAS summary statistics for sepsis and sepsis-related outcomes came from the UK Biobank. The inverse-variance weighted (IVW) approach was the primary method used to examine the causal association. To complement the IVW method, we utilized four additional MR methods. We performed a series of sensitivity analyses to examine the robustness of the causal estimates. Results We assessed the causality of 196 bacterial traits on sepsis and sepsis-related outcomes. Genus Coprococcus2 [odds ratio (OR) 0.81, 95% confidence interval (CI) (0.69–0.94), p = 0.007] and genus Dialister (OR 0.85, 95% CI 0.74–0.97, p = 0.016) had a protective effect on sepsis, whereas genus Ruminococcaceae UCG011 (OR 1.10, 95% CI 1.01–1.20, p = 0.024) increased the risk of sepsis. When it came to sepsis requiring critical care, genus Anaerostipes (OR 0.49, 95% CI 0.31–0.76, p = 0.002), genus Coprococcus1 (OR 0.65, 95% CI 0.43–1.00, p = 0.049), and genus Lachnospiraceae UCG004 (OR 0.51, 95% CI 0.34–0.77, p = 0.001) emerged as protective factors. Concerning 28-day mortality of sepsis, genus Coprococcus1 (OR 0.67, 95% CI 0.48–0.94, p = 0.020), genus Coprococcus2 (OR 0.48, 95% CI 0.27–0.86, p = 0.013), genus Lachnospiraceae FCS020 (OR 0.70, 95% CI 0.52–0.95, p = 0.023), and genus Victivallis (OR 0.82, 95% CI 0.68–0.99, p = 0.042) presented a protective effect, whereas genus Ruminococcus torques group (OR 1.53, 95% CI 1.00–2.35, p = 0.049), genus Sellimonas (OR 1.25, 95% CI 1.04–1.50, p = 0.019), and genus Terrisporobacter (OR 1.43, 95% CI 1.02–2.02, p = 0.040) presented a harmful effect. Furthermore, genus Coprococcus1 (OR 0.42, 95% CI 0.19–0.92, p = 0.031), genus Coprococcus2 (OR 0.34, 95% CI 0.14–0.83, p = 0.018), and genus Ruminiclostridium6 (OR 0.43, 95% CI 0.22–0.83, p = 0.012) were associated with a lower 28-day mortality of sepsis requiring critical care. Conclusion This MR analysis unveiled a causality between the 21 bacterial traits and sepsis and sepsis-related outcomes. Our findings may help the development of novel microbiota-based therapeutics to decrease the morbidity and mortality of sepsis.

Association Between Gut Dysbiosis and Sepsis-Induced Myocardial Dysfunction in Patients With Sepsis or Septic Shock

Multi-biomarker Strategy for Prediction of Myocardial Dysfunction and Mortality in Sepsis

Dysbiosis of the Intestinal Microbiota in Neurocritically Ill Patients and the Risk for Death.

Sirt3 is a Novel Target to Treat Sepsis Induced Myocardial Dysfunction by Acetylated Modulation of Critical Enzymes Within Cardiac Tricarboxylic Acid Cycle

Gut microbiota involved in myocardial dysfunction induced by sepsis

Causal associations of gut microbiota and metabolites on sepsis: a two-sample Mendelian randomization study

Relationship between gut microbiota dysbiosis and immune indicator in children with sepsis

[Research progress on the relationship between the gut microbiota dysbiosis and sepsis-induced cardiomyopathy]

Gut microbiota composition and changes in patients with sepsis: potential markers for predicting survival

Causal effects of gut microbiota on sepsis and sepsis-related death: insights from genome-wide Mendelian randomization, single-cell RNA, bulk RNA sequencing, and network pharmacology

Altered Gut Microbiota Taxonomic Compositions of Patients with Sepsis in a Pediatric Intensive Care Unit

Analysis of metabolic disturbances attributable to sepsis-induced myocardial dysfunction using metabolomics and transcriptomics techniques

Gut microbiota and sepsis and sepsis-related death: a Mendelian randomization investigation

Causal associations between gut microbiota and sepsis: A two‐sample Mendelian randomization study

Blood microbial signatures associated with mortality in patients with sepsis: A pilot study

Altered intestinal microbiome and metabolome correspond to the clinical outcome of sepsis

Gut-muscle axis and sepsis-induced myopathy: The potential role of gut microbiota

The causality of gut microbiota on onset and progression of sepsis: a bi-directional Mendelian randomization analysis

Causal effects of gut microbiota on sepsis: a two-sample Mendelian randomization study

Gut microbiota profiles in critically ill patients, potential biomarkers and risk variables for sepsis

Analysis of the dynamic changes in gut microbiota in patients with different severity in sepsis